A fourth dose of Pfizer-BioNTech’s vaccine was insufficient to prevent infection
18-01-2022, 07:33 PM
A fourth dose of Pfizer-BioNTech’s vaccine was insufficient to prevent infection against omicron, according to preliminary trial data from Israel. https://bloom.bg/3IhPspl
18-01-2022, 08:52 PM
how about combining 5tg and 6th? sure sufficient
18-01-2022, 09:20 PM
more variant in the making.
then the west can sell more 'koyok' to the world
then the west can sell more 'koyok' to the world
18-01-2022, 09:23 PM
18-01-2022, 09:32 PM
They dun realise the more doses they have the variant has learned n adapted to go around d vaccine?
There is no right or wrong decisions.
One only has to bear the consequences that one makes
18-01-2022, 09:32 PM
Don't worry one can use the Pfizer pills in the meantime.
Paxlovid is meant to be taken as 30 pills over five days. About USD530 per person.
Once the Omicron-specific vaccine is out in March or June, one can then go for it again.
Paxlovid is meant to be taken as 30 pills over five days. About USD530 per person.
Once the Omicron-specific vaccine is out in March or June, one can then go for it again.
18-01-2022, 09:34 PM
18-01-2022, 09:37 PM
Singapore also tried experimental drugs for patients.
18-01-2022, 09:59 PM
After two Pfizer, can wait how long maximum then do booster to remain vaccinated status?
19-01-2022, 12:29 AM
(18-01-2022, 09:32 PM)theold Wrote: Don't worry one can use the Pfizer pills in the meantime.
Paxlovid is meant to be taken as 30 pills over five days. About USD530 per person.
Once the Omicron-specific vaccine is out in March or June, one can then go for it again.
Omicron is decade differences with older circulation variants,
thus specific would be better.
But in the first place jab vaccine cannot prevent infection
as it produce antibodies in the blood vessels and organ
not the main entry points, nose and lung side.
« Next Oldest | Next Newest »
Users browsing this thread: 7 Guest(s)